AAAAAA

   
Results: 1-10 |
Results: 10
THE CLONOGENIC CAPACITY AND THE NUMBER OF CLONOGENIC CELLS IN THE PERIPHERAL-BLOOD AND BONE-MARROW DURING FILGRASTIM MOBILIZATION OF CD34+ CELLS IN HEALTHY DONORS FOR ALLOGENEIC PBSCT
Authors: KNOPINSKAPOSLUSZNY W ZAUCHA JM BIENIASZEWSKA M HELLMANN A
Citation: W. Knopinskaposluszny et al., THE CLONOGENIC CAPACITY AND THE NUMBER OF CLONOGENIC CELLS IN THE PERIPHERAL-BLOOD AND BONE-MARROW DURING FILGRASTIM MOBILIZATION OF CD34+ CELLS IN HEALTHY DONORS FOR ALLOGENEIC PBSCT, Bone marrow transplantation, 21, 1998, pp. 18-18
ALLOGENEIC PBSCT - IS ACUTE GVHD RISK INCREASED IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA (CML)
Authors: ZAUCHA JM KNOPINSKAPOSLUSZNY W LEWANDOWSKI K HALABURDA K BIENIASZEWSKA M HELLMANN A
Citation: Jm. Zaucha et al., ALLOGENEIC PBSCT - IS ACUTE GVHD RISK INCREASED IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA (CML), Bone marrow transplantation, 21, 1998, pp. 40-40
THE LONG-TERM SAFETY OF THE PBSC MOBILIZATION IN HEALTHY DONORS
Authors: BIENIASZAWSKA M KNOPINSKAPOSLUSZNY W ZAUCHA JM HALABURDA K HELLMANN A
Citation: M. Bieniaszawska et al., THE LONG-TERM SAFETY OF THE PBSC MOBILIZATION IN HEALTHY DONORS, Bone marrow transplantation, 21, 1998, pp. 156-156
CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) - A SURVEY OF THE INFECTIOUS-DISEASES WORKING PARTY OF EBMT
Authors: LINK H ARSENIEV L LJUNGMAN P ALESSANDRINO EP AMADORI S BANDINI G BEGUIN Y BRINCH L BRUNET S CHOPRA R CORDONNIER C DEWITTE T FAUSER A FERRANT A GARCIACONDE J JULIUSSON G KUBEL M MANNA AT MARTINEZRUBIO AM MUNDHENK P ORDEMANN R ORTEGA JJ POTTER M PRENTICE HG RAIMONDI R REMEZ K REUSSER P ROVIRA M RUSSELL J SELLESLAG D UDERZO C ZAUCHA JM
Citation: H. Link et al., CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) - A SURVEY OF THE INFECTIOUS-DISEASES WORKING PARTY OF EBMT, Bone marrow transplantation, 21, 1998, pp. 479-479
TREATMENT OF WALDENSTROMS-MACROGLOBULINEMIA WITH 2-CHLORODEOXYADENOSINE
Authors: HELLMANN A LEWANDOWSKI K ZAUCHA JM BIENIASZEWSKA M ROBAK T
Citation: A. Hellmann et al., TREATMENT OF WALDENSTROMS-MACROGLOBULINEMIA WITH 2-CHLORODEOXYADENOSINE, British Journal of Haematology, 102(1), 1998, pp. 244-244
ACTIVITY OF 2-CHLORODEOXYADENOSINE (CLADRIBINE) IN 2-HOUR INTRAVENOUS-INFUSION IN 94 PREVIOUSLY TREATED PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMA
Authors: ROBAK T GORATYBOR J KRYKOWSKI E WALEWSKI JA BORAWSKA A PLUZANSKA A POTEMSKI P HELLMANN A ZAUCHA JM KONOPKA L CEGLAREK B DURZYNSKI T SIKORSKA A MICHALAK K URASINSKI J OPALINSKA J DMOSZYNSKA A ADAMCZYKCIOCH MB KURATOWSKA Z DWILEWICZTROJACZEK J BOGURADZKI P DEREN M MAJ S GRIEB P
Citation: T. Robak et al., ACTIVITY OF 2-CHLORODEOXYADENOSINE (CLADRIBINE) IN 2-HOUR INTRAVENOUS-INFUSION IN 94 PREVIOUSLY TREATED PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 26(1-2), 1997, pp. 99-105
CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) - A SURVEY OF THE INFECTIOUS-DISEASES WORKING PARTY OF EBMT
Authors: LINK H ARSENIEV L LJUNGMAN P ALESSANDRINO EP AMADORI S BANDINI G BEGUIN Y BRINCH L BRUNET S CHOPRA R CORDONNIER C DEWITTE T FAUSER A FERRANT AF GARCIACONDE J JULIUSSON G KUBEL M MANNA A MARTINEZRUBIO AM MUNDHENK P ORDEMANN R ORTEGA JJ POTTER M PRENTICE HP RAIMONDI R REMEZ K REUSSER P ROVIRA M RUSSELL J SELLESLAG D UDERZO C ZAUCHA JM
Citation: H. Link et al., CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) - A SURVEY OF THE INFECTIOUS-DISEASES WORKING PARTY OF EBMT, Blood, 90(10), 1997, pp. 2424-2424
2-CHLORODEOXYADENOSINE TREATMENT IN THE SEZARY-SYNDROME
Authors: ZAUCHA JM LEWANDOWSKI K HELLMANN A PAWLIK H SIEDLEWICZ A
Citation: Jm. Zaucha et al., 2-CHLORODEOXYADENOSINE TREATMENT IN THE SEZARY-SYNDROME, Blood, 89(4), 1997, pp. 1462-1463
INTERMITTENT 2-HOUR INTRAVENOUS INFUSIONS OF 2-CHLORODEOXYADENOSINE IN THE TREATMENT OF 110 PATIENTS WITH REFRACTORY OR PREVIOUSLY UNTREATED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: ROBAK T BLASINKAMORAWIEC M KRYKOWSKI E KASZNICKI M PLUZANSKA A POTEMSKI P HELLMANN A ZAUCHA JM LEWANDOWSKI K DMOSZYNSKA A HANSZ J KOMARNICKI M KONOPKA I DURZYNSKI T CEGLAREK B SIKORSKA A KOTLAREKHAUS S MAZUR G URASINSKI I ZDZIARSKA B MAJ S KOPEC I SKOTNICKI AB DWILEWICZTROJACZEK J KURATOWSKA Z GRIEB P
Citation: T. Robak et al., INTERMITTENT 2-HOUR INTRAVENOUS INFUSIONS OF 2-CHLORODEOXYADENOSINE IN THE TREATMENT OF 110 PATIENTS WITH REFRACTORY OR PREVIOUSLY UNTREATED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia & lymphoma, 22(5-6), 1996, pp. 509-514
2-CHLORODEOXYADENOSINE (2-CDA) IN 2-HOUR VERSUS 24-HOUR INTRAVENOUS-INFUSION IN THE TREATMENT OF PATIENTS WITH HAIRY-CELL LEUKEMIA
Authors: ROBAK T BLASINSKAMORAWIEC M KRYKOWSKI E HANSZ J KOMARNICKI M KAZIMIERCZAK M KONOPKA L MAJ S HELLMANN A ZAUCHA JM URASINSKI L ZDZIARSKA B KOTLAREKHAUS S USNARSKAZUBKIEWICZ L KURATOWSKA Z DWILEWICZTROJACZEK J HOLOWIECKI J KRAWCZYKKULIS M GRIEB P
Citation: T. Robak et al., 2-CHLORODEOXYADENOSINE (2-CDA) IN 2-HOUR VERSUS 24-HOUR INTRAVENOUS-INFUSION IN THE TREATMENT OF PATIENTS WITH HAIRY-CELL LEUKEMIA, Leukemia & lymphoma, 22(1-2), 1996, pp. 107-111
Risultati: 1-10 |